Global Aminoglycosides Antibiotics Competitive Landscape Professional Research Report 2025
Research Summary
Aminoglycosides are a class of antibiotics that are primarily used to treat bacterial infections. They work by breaking down bacterial cell walls and preventing the bacteria from replicating. Aminoglycosides are typically administered intravenously and can be used to treat a wide range of infections, including those caused by gram-negative bacteria and tuberculosis. Some common examples of aminoglycoside antibiotics include gentamicin, amikacin, and tobramycin. However, the use of aminoglycosides is associated with potential side effects, including damage to the kidneys and inner ear, and they should only be used under the guidance of a healthcare professional.
According to DIResearch's in-depth investigation and research, the global Aminoglycosides Antibiotics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Aminoglycosides Antibiotics include Jemicare, Teva, Novartis, Fangyuan-pharma, Aike Pharmaceutical, Cipla, Pfizer, Fresenius Kabi, Sun Pharma, Hikma, Lannett Company etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Aminoglycosides Antibiotics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Aminoglycosides Antibiotics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Aminoglycosides Antibiotics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Aminoglycosides Antibiotics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Aminoglycosides Antibiotics Include:
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company
Aminoglycosides Antibiotics Product Segment Include:
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others
Aminoglycosides Antibiotics Product Application Include:
Hospital
Clinic
Post Care Facility
Government & Military
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Aminoglycosides Antibiotics Industry PESTEL Analysis
Chapter 3: Global Aminoglycosides Antibiotics Industry Porter’s Five Forces Analysis
Chapter 4: Global Aminoglycosides Antibiotics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Aminoglycosides Antibiotics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Aminoglycosides Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Aminoglycosides Antibiotics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Aminoglycosides Antibiotics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Aminoglycosides Antibiotics Product by Type
- 1.2.1 Neomycin
- 1.2.2 Tobramycin
- 1.2.3 Gentamicin
- 1.2.4 Amikacin
- 1.2.5 Etimicin
- 1.2.6 Others
- 1.3 Aminoglycosides Antibiotics Product by Application
- 1.3.1 Hospital
- 1.3.2 Clinic
- 1.3.3 Post Care Facility
- 1.3.4 Government & Military
- 1.3.5 Others
- 1.4 Global Aminoglycosides Antibiotics Market Size Analysis (2020-2032)
- 1.5 Aminoglycosides Antibiotics Market Development Status and Trends
- 1.5.1 Aminoglycosides Antibiotics Industry Development Status Analysis
- 1.5.2 Aminoglycosides Antibiotics Industry Development Trends Analysis
- 2 Aminoglycosides Antibiotics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Aminoglycosides Antibiotics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Aminoglycosides Antibiotics Market Analysis by Regions
- 4.1 Aminoglycosides Antibiotics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Aminoglycosides Antibiotics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Aminoglycosides Antibiotics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Aminoglycosides Antibiotics Revenue Forecast by Region (2026-2032)
- 5 Global Aminoglycosides Antibiotics Market Size by Type and Application
- 5.1 Global Aminoglycosides Antibiotics Market Size by Type (2020-2032)
- 5.2 Global Aminoglycosides Antibiotics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Aminoglycosides Antibiotics Market Size by Type
- 6.4 North America Aminoglycosides Antibiotics Market Size by Application
- 6.5 North America Aminoglycosides Antibiotics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Aminoglycosides Antibiotics Market Size by Type
- 7.4 Europe Aminoglycosides Antibiotics Market Size by Application
- 7.5 Europe Aminoglycosides Antibiotics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Aminoglycosides Antibiotics Market Size by Type
- 8.4 China Aminoglycosides Antibiotics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Aminoglycosides Antibiotics Market Size by Type
- 9.4 APAC (excl. China) Aminoglycosides Antibiotics Market Size by Application
- 9.5 APAC (excl. China) Aminoglycosides Antibiotics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Aminoglycosides Antibiotics Market Size by Type
- 10.4 Latin America Aminoglycosides Antibiotics Market Size by Application
- 10.5 Latin America Aminoglycosides Antibiotics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Aminoglycosides Antibiotics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Aminoglycosides Antibiotics Market Size by Type
- 11.4 Middle East & Africa Aminoglycosides Antibiotics Market Size by Application
- 11.5 Middle East & Africa Aminoglycosides Antibiotics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Aminoglycosides Antibiotics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Aminoglycosides Antibiotics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Aminoglycosides Antibiotics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Jemicare
- 13.1.1 Jemicare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Jemicare Aminoglycosides Antibiotics Product Portfolio
- 13.1.3 Jemicare Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Teva
- 13.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Teva Aminoglycosides Antibiotics Product Portfolio
- 13.2.3 Teva Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Novartis
- 13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Novartis Aminoglycosides Antibiotics Product Portfolio
- 13.3.3 Novartis Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Fangyuan-pharma
- 13.4.1 Fangyuan-pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio
- 13.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Aike Pharmaceutical
- 13.5.1 Aike Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio
- 13.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Cipla
- 13.6.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Cipla Aminoglycosides Antibiotics Product Portfolio
- 13.6.3 Cipla Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Pfizer
- 13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Pfizer Aminoglycosides Antibiotics Product Portfolio
- 13.7.3 Pfizer Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Fresenius Kabi
- 13.8.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio
- 13.8.3 Fresenius Kabi Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Sun Pharma
- 13.9.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Sun Pharma Aminoglycosides Antibiotics Product Portfolio
- 13.9.3 Sun Pharma Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Hikma
- 13.10.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Hikma Aminoglycosides Antibiotics Product Portfolio
- 13.10.3 Hikma Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Lannett Company
- 13.11.1 Lannett Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Lannett Company Aminoglycosides Antibiotics Product Portfolio
- 13.11.3 Lannett Company Aminoglycosides Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Aminoglycosides Antibiotics Industry Chain Analysis
- 14.2 Aminoglycosides Antibiotics Industry Raw Material and Suppliers Analysis
- 14.2.1 Aminoglycosides Antibiotics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Aminoglycosides Antibiotics Typical Downstream Customers
- 14.4 Aminoglycosides Antibiotics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook